Ultrasound-Guided Supra-Inguinal Fascia Iliaca Block As an Anesthesia Method for Lower Extremity Surgeries: A Single-Center Retrospective Cohort Feasibility Study
Sponsor study identifier
observational
16
1 country
1
Study Start
March 1, 2022
Actual (reported)Primary Completion
March 1, 2023
Actual (reported)Study Completion
March 15, 2023
Actual (reported)The Ultrasound-guided Supra-inguinal Fascia Iliaca Block (SIFIB) is an advanced regional anesthesia technique strategically directed at the three primary nerves of the lumbar plexus. As the scope of regional anesthesia methods continues to grow in clinical application, this approach emerges as a versatile method. It can be used independently for pain management or as the primary anesthetic method, particularly in well-selected patients undergoing isolated limb surgeries or in combination with other regional anesthesia approaches.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 15, 2023
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 1, 2022
Actual (reported)March 1, 2023
Actual (reported)March 15, 2023
Actual (reported)September 25, 2023
Actual (reported)October 10, 2023
Actual (reported)Block Success which provided surgical anesthesia, intraoperatively
After performing the blocks, the sensory block was examined with a pinprick test using a 27-gauge hypodermic needle, (0 = no sensory block; 1 = tactile sense present, no pain; 2 = no tactile sense and no pain). Cases with a score of 1 or 2 after 30 min were considered successful.
Intraoperatively and PACU unit (up to 2 hours)
Additional analgesic requirement
Intraoperatively and PACU unit (up to 2 hours)
The design of this study involved the retrospective analysis of data. Data was gathered from adult patients falling into the American Society of Anesthesiology (ASA) categories I to III, who were scheduled for elective lower limb surgical procedures. More specifically, patients who had undergone SIFIB either as the primary anesthesia approach or as part of their anesthesia regimen were included. Those who had received general anesthesia, neuraxial anesthesia, or infiltration anesthesia were excluded from the study. Importantly, all patients who participated in the study provided written informed consent for both their involvement in the study and the publication of their data.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Specifically, we included patients who underwent SIFIB either as the primary anesthesia method or as a component of the anesthesia plan.
Samsun University
Samsun, Turkey (Türkiye)
Serkan Tulgar, M.D.
Samsun University
16 participants (actual enrollment reported by the registry).
First Submitted
September 25, 2023
First Posted
October 10, 2023
Study Start
March 1, 2022
Actual (reported)DIPB vs. SIFIB for Postoperative Analgesia After Hip Surgery
Contact the study team to confirm eligibility.
Primary Completion
March 1, 2023
Actual (reported)Study Completion
March 15, 2023
Actual (reported)Last Updated
October 10, 2023
Record last verified: 2023-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: